Congenital long QT syndrome with compound mutations in the KCNH2 gene
Sachiko Bando(Tokushima University), Masataka Sata(Tokushima University), Takeshi Aiba(National Cerebral and Cardiovascular Center), Takayuki Ise(Tokushima University Hospital), Takeshi Soeki(Tokushima University), Takashi Iwase(ENVIRON (United States)), Koji Yamaguchi(University of Occupational and Environmental Health Japan), Hirotsugu Yamada(Tokushima University Hospital), Masashi Akaike(Tokushima University), Tetsuzo Wakatsuki(Tokushima University), Toshiyuki Niki(Tokushima Prefectural Central Hospital), Tomomi Matsuura(Keio University), Yoshio Taketani(Shikoku Medical Center for Children and Adults), Wataru Shimizu(Nippon Medical School Hospital)
Cited by 5
Related Papers
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
|European Heart Journal|2018|2.1k
Distinct Metabolic Flow Enables Large-Scale Purification of Mouse and Human Pluripotent Stem Cell-Derived Cardiomyocytes
|Cell stem cell|2012|1.1k
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome
|Circulation Journal|2019|582
Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death
|Nature Genetics|2013|550
Accuracy of Cuff-Measured Blood Pressure
|Journal of the American College of Cardiology|2017|271